Bladder Cancer Screening Trial

Description

There is currently no accepted screening strategy for patients at high risk of developing bladder cancer. This study will ask patients to complete a urine test every 6 months for 2 years to help assess if routine screening helps finding bladder cancer at an earlier stage.

Conditions

Bladder Cancer, Urothelial Carcinoma, Hematuria, Smoking Cessation

Talk to us

Study Overview

On this page

Study Details

Study overview

There is currently no accepted screening strategy for patients at high risk of developing bladder cancer. This study will ask patients to complete a urine test every 6 months for 2 years to help assess if routine screening helps finding bladder cancer at an earlier stage.

Optimal Screening Strategy for Bladder Cancer in at Risk Patients

Bladder Cancer Screening Trial

Condition
Bladder Cancer
Intervention / Treatment

-

Contacts and Locations

Dallas

University of Texas Southwestern Medical Center, Dallas, Texas, United States, 75390

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Age ≥ 50
  • * Smoking: ≥15 pack-year smoking history
  • * Occupation:≥ 15 years of occupational exposures including: textile worker, painter, dry cleaners
  • * Prior history of bladder, kidney, or prostate cancer
  • * Prior evaluation of micro or gross hematuria within the last 2 years
  • * Do not provide informed consent

Ages Eligible for Study

50 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

University of Texas Southwestern Medical Center,

Yair Lotan, MD, PRINCIPAL_INVESTIGATOR, UT Southwestern Medical Center

Study Record Dates

2028-04